O'Dowd Hugh 4
4 · Neon Therapeutics, Inc. · Filed Aug 22, 2018
Insider Transaction Report
Form 4
O'Dowd Hugh
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2018-08-20$2.65/sh+18,868$50,000→ 445,868 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-08-20−18,868→ 314,607 totalExercise: $2.65→ Common Stock (18,868 underlying)
Footnotes (1)
- [F1]25% of the shares vested on September 23, 2017, with the remainder vesting over 36 equal monthly installments thereafter.